Matthew Lakelin

Vice President, Scientific Affairs & Product Development, Co-Founder • Trakcel

Dr Matthew Lakelin is a co-founder of TrakCel. Using his knowledge in handling and distribution of CGTs he has assisted with the development of the technology platform and is passionate about democratising advanced therapies. Matthew provides a technical bridge between software development and the GxP application of the system. 

Matthew holds a PhD in Pharmacology and has over 20 years of experience working in the pharmaceutical and biotechnology industry. Matthew is a TrakCel ATMP industry expert and in his role as VP of Scientific Affairs is a key spokesperson and responsible for ensuring that TrakCel solutions continue to evolve to meet industry needs. 


Also speaking

Chris Williams

Principal Engineer • DeSci Applied Research

Laura Herbst

M. Sc. Research Fellow • Fraunhofer

Amandine Breton

Director MSAT & AST, Cell & Gene Therapies • Orchard Therapeutics

Event Info


Sponsorship Opportunities Waiting List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.


Find out more about partnering at Advanced Therapies Europe.